Security National Bank grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 21,362 shares of the healthcare conglomerate’s stock after acquiring an additional 1,293 shares during the quarter. UnitedHealth Group makes up 2.1% of Security National Bank’s holdings, making the stock its 13th biggest holding. Security National Bank’s holdings in UnitedHealth Group were worth $8,347,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Anfield Capital Management LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $26,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $28,000. Activest Wealth Management purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $29,000. Finally, Ten Capital Wealth Advisors LLC raised its position in UnitedHealth Group by 111.6% in the 2nd quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock worth $36,000 after purchasing an additional 48 shares during the period. Hedge funds and other institutional investors own 86.20% of the company’s stock.
Shares of NYSE UNH traded up $3.03 during midday trading on Thursday, reaching $450.16. 2,248,836 shares of the company’s stock traded hands, compared to its average volume of 2,940,181. The company has a market cap of $423.98 billion, a price-to-earnings ratio of 27.93, a P/E/G ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a one year low of $320.35 and a one year high of $466.00. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.59. The stock’s 50 day simple moving average is $430.47 and its 200-day simple moving average is $418.01.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be paid a $1.45 dividend. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.29%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.98%.
In other news, Director Stephen J. Hemsley sold 75,000 shares of UnitedHealth Group stock in a transaction on Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction on Tuesday, September 14th. The stock was sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the transaction, the director now directly owns 154,403 shares of the company’s stock, valued at approximately $64,347,450.25. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 82,500 shares of company stock valued at $36,855,125. 0.55% of the stock is owned by insiders.
A number of research firms recently weighed in on UNH. Mizuho increased their price objective on shares of UnitedHealth Group from $455.00 to $500.00 and gave the stock a “buy” rating in a research report on Wednesday, November 10th. Evercore ISI raised their target price on shares of UnitedHealth Group from $360.00 to $480.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. Morgan Stanley raised their target price on shares of UnitedHealth Group from $488.00 to $499.00 and gave the stock an “overweight” rating in a research report on Friday, October 15th. Credit Suisse Group raised their target price on shares of UnitedHealth Group from $462.00 to $495.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. Finally, Cowen started coverage on shares of UnitedHealth Group in a research report on Thursday, September 9th. They set an “outperform” rating and a $478.00 target price on the stock. One analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $477.35.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Further Reading: Why do company’s buyback their stock?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.